This prompted us to screen the profibrotic miR-21, a TGFbeta regulator [26], and the contractile myofibroblast markers α-SMA and ED-fibronectin in fibroblast cultures obtained from EDMD patients carrying mutations in different genes. This evidence concerns the gene FN1 and Emery-Dreifuss muscular dystrophy.